ED
EVHC

Exane Derivatives’s Envision Healthcare Holdings Inc EVHC Stock Holding History

Exane Derivatives’s Portfolio EVHC Stock Details EVHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-16
Closed -$731 – 766
2018
Q3 		$731 Sell
16
-4,929
-100% -$221K ﹤0.01% 563
2018
Q2 		$218K Sell
4,945
-10,501
-68% -$431K 0.04% 253
2018
Q1 		$589K Sell
15,446
-10,520
-41% -$393K 0.12% 154
2017
Q4 		$897K Buy
25,966
+15,392
+146% +$538K 0.15% 106
2017
Q3 		$475K Buy
+10,574
New +$564K 0.09% 140

Other funds holding EVHC

SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

Exane Derivatives's EVHC Position: Q4 2018 in Review

Exane Derivatives sold out of Envision Healthcare Holdings Inc (EVHC) in Q4 2018, closing a stake of 16 shares — an estimated $731 sold.

Exane Derivatives first reported a position in EVHC in Q3 2017 and held it in 5 quarters. The position peaked at $897K in Q4 2017. 4 funds tracked by Wall St. Rank hold EVHC as of Q4 2018.

  • Exane Derivatives reported no remaining Envision Healthcare Holdings Inc position as of Q4 2018 after selling out during the quarter.
  • Exane Derivatives sold 16 Envision Healthcare Holdings Inc shares in Q4 2018, an estimated $731.
  • Exane Derivatives first reported a position in Envision Healthcare Holdings Inc in Q3 2017 and held it in 5 quarters.
  • Exane Derivatives's Envision Healthcare Holdings Inc position peaked at $897K in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Envision Healthcare Holdings Inc as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.